Company Filing History:
Years Active: 2009
Title: Gudrun Sauerbier: Innovator in Female Infertility Treatment
Introduction
Gudrun Sauerbier is a prominent inventor and legal representative based in Halle, Germany. She has made significant contributions to the field of reproductive health, particularly in the treatment of female infertility. Her innovative work has led to the development of a unique lyophilizate that offers new possibilities for addressing this critical health issue.
Latest Patents
Sauerbier holds a patent for an oligopeptide lyophilisate, which includes its preparation and use. This novel lyophilizate is designed to treat female infertility and provide gonad protection. The preparation method involves dissolving Cetrorelix in a 30% v/v acetic acid solution, which is then transferred to water and freeze-dried. This innovative approach has the potential to improve treatment outcomes for women facing infertility challenges.
Career Highlights
Throughout her career, Gudrun Sauerbier has been associated with Aeterna Zentaris GmbH, where she has played a vital role in advancing research and development in reproductive health. Her expertise and dedication have positioned her as a key figure in the company, contributing to its mission of improving patient care through innovative solutions.
Collaborations
Sauerbier has collaborated with notable colleagues, including Jürgen Engel and Burkhard Wichert. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, ultimately enhancing the quality of research and development efforts.
Conclusion
Gudrun Sauerbier's contributions to the field of female infertility treatment through her innovative patent demonstrate her commitment to advancing healthcare solutions. Her work at Aeterna Zentaris GmbH and collaborations with esteemed colleagues highlight her significant impact in this vital area of research.